Bristol-Myers Squibb (NYSE:BMY) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.26, beating the consensus estimate of $1.19 by $0.07 per share. Revenue came in at $12.5B, beating the estimate of $12.3B.
Bristol-Myers Squibb's stock moved following the earnings release. The stock currently trades at $60.94 with a market capitalization of $104.2B.


